BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11715395)

  • 1. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
    Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
    Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP; Malta AM; Sarno EN; Kaplan G
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum.
    Sharma NL; Sharma V; Shanker V; Mahajan VK; Sarin S
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bullous erythema nodosum leprosum. A case report in French Guiana].
    Couppié P; Sainte-Marie D; About V; Heid E; Pradinaud R
    Ann Dermatol Venereol; 1998 Mar; 125(3):188-90. PubMed ID: 9747246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of erythema nodosum leprosum using thalidomide].
    Sheskin J
    Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept in erythema nodosum leprosum.
    Santos JRS; Vendramini DL; Nery JADC; Avelleira JCR
    An Bras Dermatol; 2017; 92(4):575-577. PubMed ID: 28954119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thalidomide used by patients with erythema nodosum leprosum].
    Valente Mdo S; Vieira JL
    Rev Soc Bras Med Trop; 2010; 43(2):201-4. PubMed ID: 20464154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leprosy and the testis].
    Rodríguez G; Abaúnza MC; Vargas EJ; López F
    Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case Report: Rapid Response to Low-Dose Thalidomide in a Case of Severe Steroid Recalcitrant Erythema Nodosum Leprosum.
    Savitha B; Sardana K; Kumari R; Khurana A; Sinha S; Sachdeva S
    Am J Trop Med Hyg; 2021 Oct; 106(1):51-53. PubMed ID: 34662871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
    Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
    Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lepromatous leprosy in Saudi female from central region.
    al-Majed S
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
    Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
    Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe vasculonecrotic erythema nodosum leprosum following thalidomide withdrawal without tapering doses: do we have something unusual?
    Mahajan VK; Chauhan PS; Sharma NL; Sharma AL; Mehta KS
    Braz J Infect Dis; 2011; 15(1):90-1. PubMed ID: 21412598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.